HPV vaccination is highly effective and cost‐effective for cervical cancer prevention in women living with HIV in China: A cost‐effectiveness analysis

Documenti analoghi

• Reply to ‘Comments on “ HPV vaccination is highly effective and cost‐effective for cervical cancer prevention in women living with HIV in China: A cost‐effectiveness analysis”’
  di: Hanting Liu, et al.
  Pubblicazione: (2025)
• Comments on “ HPV vaccination is highly effective and cost‐effective for cervical cancer prevention in women living with HIV in China: A cost‐effectiveness analysis”
  di: Zhongyi Liu, et al.
  Pubblicazione: (2025)
• Cost‐effectiveness analysis of human papillomavirus ( HPV ) genotyping strategies for management of HPV ‐positive women in cervical cancer screening
  di: Kelsi R. Kroon, et al.
  Pubblicazione: (2026)
• Field experience with the 8‐HPV‐type oncoprotein test for cervical cancer screening among HPV‐positive women living with and without HIV in LMICs
  di: Laura Downham, et al.
  Pubblicazione: (2024)
• Is the beneficial effect of multi‐cohort HPV vaccination on cervical cancer and precancerous lesions seen across all educational levels?
  di: Rose M. W. Rasmussen, et al.
  Pubblicazione: (2026)